Animal Models and Retroviral Vaccines section (AMRVS) Retrovirus Assay, Reagent, and Viral Stock Preparation Support

Closed Solicitation Posted

Solicitation number
75N91024Q00011
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

This solicitation seeks laboratory services to support the Animal Models and Retroviral Vaccines section of the National Cancer Institute, including immunological assays, virological assays, reagent preparation, and viral stock preparation. Services will be provided under an IDIQ contract with a ceiling of $19 million to the Department of Health and Human Services National Institutes of Health National Cancer Institute. Offerors must have BSL-2 facilities with BSL-3 practices and the ability to handle human and non-human primate retroviruses. The deadline for responses is January 31, 2024 and evaluation will be based on technical experience, past performance, and price.

The NAICS code is 541380 for testing laboratories and services, with a size standard of $19 million. There is no set-aside designation. Services will involve tasks such as the shipping and distribution of up to 1,000 biological specimens per lot, the production of overlapping peptide arrays representing various retrovirus genomes, and the preparation of viral stocks to a titer of 1010 PFU. The period of performance is the base year plus four option years. One award will be made and the place of performance is within the United States.

Notice text

3 versions

Update #3 · Latest ·

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Vaccine Branch (VB), Retroviral Vaccines Branch (RVB), has a need for Laboratory Services for Immunological Assays, Virological Assays, Reagent and Viral Stock Preparation.

This is a Combined Synopsis/Solicitation for commercial items, prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, as supplemented with additional information included in this notice, and shall be processed in accordance with FAR 13.5 – (Simplified Procedures for Certain Commercial Products and Commercial Services). This
announcement constitutes the only solicitation that will be provided in relation to the stated need contained herein. This solicitation is issued as a Request for Quote (RFQ) and includes applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2024-06 (12/04/2023)

The requirement’s North American Industry Classification System (NAICS) code is 541380 (Testing Laboratories and Services) with a size standard of $19.0 Million. One single award, the Indefinite Delivery Indefinite Quantity (IDIQ) award is anticipated to be
made as a result of this solicitation.

Amendment No.: A0002:

The purpose of this amendment is to revise the inital Taks Orders (TO) estimated period of performance.

All other RFQ information, terms, conditions, and due dates reamin unchanged.  

**Please see documents entitled "Amended_TaskOrder_SOW" for more details***

Update #2 ·

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Vaccine Branch (VB), Retroviral Vaccines Branch (RVB), has a need for Laboratory Services for Immunological Assays, Virological Assays, Reagent and Viral Stock Preparation.

This is a Combined Synopsis/Solicitation for commercial items, prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, as supplemented with additional information included in this notice, and shall be processed in accordance with FAR 13.5 – (Simplified Procedures for Certain Commercial Products and Commercial Services). This
announcement constitutes the only solicitation that will be provided in relation to the stated need contained herein. This solicitation is issued as a Request for Quote (RFQ) and includes applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2024-06 (12/04/2023)

The requirement’s North American Industry Classification System (NAICS) code is 541380 (Testing Laboratories and Services) with a size standard of $19.0 Million. One single award, the Indefinite Delivery Indefinite Quantity (IDIQ) award is anticipated to be
made as a result of this solicitation.

Amendment No.: A0001:

The purpose of this amendment is to extend the response due date for quotation submittal to Wednesday, January 31, 2024, by 10:00 AM EST, as well as provide the Government's response to questions submitted by vendors by the question submittal due date of 12/18/2023.

**Please see documents entitled "QandA_Response_75N91024Q00011" and "RFQ_A0001_75N91024Q00011" for additional details.***

Update #1 ·

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Vaccine Branch (VB), Retroviral Vaccines Branch (RVB), has a need for Laboratory Services for Immunological Assays, Virological Assays, Reagent and Viral Stock Preparation.


This is a Combined Synopsis/Solicitation for commercial items, prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, as supplemented with additional information included in this notice, and shall be processed in accordance with FAR 13.5 – (Simplified Procedures for Certain Commercial Products and Commercial Services). This
announcement constitutes the only solicitation that will be provided in relation to the stated need contained herein. This solicitation is issued as a Request for Quote (RFQ) and includes applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2024-06 (12/04/2023)

The requirement’s North American Industry Classification System (NAICS) code is 541380 (Testing Laboratories and Services) with a size standard of $19.0 Million. One single award, the Indefinite Delivery Indefinite Quantity (IDIQ) award is anticipated to be
made as a result of this solicitation.

**Please see attached RFQ for the Statement of Work (SOW), submittal instructions, evaluation criteria, and terms and Conditions.**

Files

File Type Posted
Amended_TaskOrder_SOW.pdf PDF
QandA_Response_75N91024Q00011..xlsx XLSX spreadsheet
RFQ_A0001_75N91024Q00011.pdf PDF
Attachment_3_Points of Contact Form.pdf PDF
Attachment_4_QandA_Submittal.xlsx XLSX spreadsheet
Attachment_2_IDIQ_PriceSchedule.xlsx XLSX spreadsheet
RFQ_75N91024Q00011.pdf PDF
Inital_TO_SOW.pdf PDF
Attachment_5_HHS SubContracting Plan.pdf PDF
Attachment_1_52.212-3_FullText.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
Pre-Clinical Models of Infectious Diseases United States · NAICS 541714 National Institute of Allergy and Infectious Diseases No set-aside
NAHLN Diagnostic Testing Services Ames, Iowa 50010, United States · NAICS 541940 Marketing and Regulatory Programs Business Services No set-aside
Reagents and consumables for Roche immunostainers Bethesda, Maryland 20892, United States · NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases NAICS 541715 National Institute of Allergy and Infectious Diseases No set-aside
NWI Offsite Pathology Services Nebraska 68105, United States · NAICS 621511 Veterans Integrated Service Network 23 Total Small Business

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors